Neurobehavioral manifestations of symptomatic HIV-1 disease in children: Can nutritional factors play a role?

Pim Brouwers, Charles DeCarli, Melvyn P. Heyes, Howard A. Moss, Pamela L. Wolters, Gareth Tudor-Williams, Lucy A. Civitello, Philip A. Pizzo

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Central nervous system (CNS) abnormalities are significant and frequent complications of human immunodeficiency virus (HIV-1) infection in infants and children. Although the predominant cause of neurological and neuropsychological abnormalities appears to be related to HIV infection of the CNS, other factors including malnutrition may also play a role. We retrospectively evaluated the association of change in body weight with changes in neurocognitive function, ventricular brain ratio, and cerebrospinal quinolinic acid levels in a small cohort of children (n=15; mean age 6.3 years) with symptomatic HIV-1 disease before and after 6 months of antiretroviral therapy with continuous intravenous infusion of zidovudine (ZVD). Significant increases in weight and neurocognitive function as well as decreases in ventricular brain ratio and cerebrospinal quinolinic acid levels were noted after therapy. Only the relation between increase in weight and decrease in ventricular brain ratio was statistically significant (P< .01); contrary to expectations, an increase in weight seemed to correlate with a decrease in neurocognitive function (NS). Another group of children treated at the same time with oral intermittent ZVD, but otherwise receiving the same care did not show the same magnitude of improvement in neurocognitive function. These results seem to suggest that general supportive and medical care as well as nutritional factors may only play a limited role in the neurocognitive improvements after antiretroviral therapy with continuous infusion ZVD. Our sample size was, however, small and the nutritional measure rather global; thus these findings have to be considered as very preliminary.

Original languageEnglish (US)
JournalJournal of Nutrition
Volume126
Issue number10 SUPPL.
StatePublished - Oct 1996
Externally publishedYes

Fingerprint

Neurobehavioral Manifestations
Zidovudine
Human immunodeficiency virus 1
Quinolinic Acid
HIV-1
brain
Weights and Measures
therapeutics
HIV Infections
central nervous system
Brain
Central Nervous System
Nervous System Malformations
Body Weight Changes
Ventricular Function
acids
body weight changes
Human immunodeficiency virus
HIV infections
Intravenous Infusions

Keywords

  • brain imaging
  • encephalopathy
  • human
  • neuropsychological test
  • pediatric HIV-1 disease

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Food Science

Cite this

Brouwers, P., DeCarli, C., Heyes, M. P., Moss, H. A., Wolters, P. L., Tudor-Williams, G., ... Pizzo, P. A. (1996). Neurobehavioral manifestations of symptomatic HIV-1 disease in children: Can nutritional factors play a role? Journal of Nutrition, 126(10 SUPPL.).

Neurobehavioral manifestations of symptomatic HIV-1 disease in children : Can nutritional factors play a role? / Brouwers, Pim; DeCarli, Charles; Heyes, Melvyn P.; Moss, Howard A.; Wolters, Pamela L.; Tudor-Williams, Gareth; Civitello, Lucy A.; Pizzo, Philip A.

In: Journal of Nutrition, Vol. 126, No. 10 SUPPL., 10.1996.

Research output: Contribution to journalArticle

Brouwers, P, DeCarli, C, Heyes, MP, Moss, HA, Wolters, PL, Tudor-Williams, G, Civitello, LA & Pizzo, PA 1996, 'Neurobehavioral manifestations of symptomatic HIV-1 disease in children: Can nutritional factors play a role?', Journal of Nutrition, vol. 126, no. 10 SUPPL..
Brouwers P, DeCarli C, Heyes MP, Moss HA, Wolters PL, Tudor-Williams G et al. Neurobehavioral manifestations of symptomatic HIV-1 disease in children: Can nutritional factors play a role? Journal of Nutrition. 1996 Oct;126(10 SUPPL.).
Brouwers, Pim ; DeCarli, Charles ; Heyes, Melvyn P. ; Moss, Howard A. ; Wolters, Pamela L. ; Tudor-Williams, Gareth ; Civitello, Lucy A. ; Pizzo, Philip A. / Neurobehavioral manifestations of symptomatic HIV-1 disease in children : Can nutritional factors play a role?. In: Journal of Nutrition. 1996 ; Vol. 126, No. 10 SUPPL.
@article{58b790ebd3f043ec9733eaf927886d3f,
title = "Neurobehavioral manifestations of symptomatic HIV-1 disease in children: Can nutritional factors play a role?",
abstract = "Central nervous system (CNS) abnormalities are significant and frequent complications of human immunodeficiency virus (HIV-1) infection in infants and children. Although the predominant cause of neurological and neuropsychological abnormalities appears to be related to HIV infection of the CNS, other factors including malnutrition may also play a role. We retrospectively evaluated the association of change in body weight with changes in neurocognitive function, ventricular brain ratio, and cerebrospinal quinolinic acid levels in a small cohort of children (n=15; mean age 6.3 years) with symptomatic HIV-1 disease before and after 6 months of antiretroviral therapy with continuous intravenous infusion of zidovudine (ZVD). Significant increases in weight and neurocognitive function as well as decreases in ventricular brain ratio and cerebrospinal quinolinic acid levels were noted after therapy. Only the relation between increase in weight and decrease in ventricular brain ratio was statistically significant (P< .01); contrary to expectations, an increase in weight seemed to correlate with a decrease in neurocognitive function (NS). Another group of children treated at the same time with oral intermittent ZVD, but otherwise receiving the same care did not show the same magnitude of improvement in neurocognitive function. These results seem to suggest that general supportive and medical care as well as nutritional factors may only play a limited role in the neurocognitive improvements after antiretroviral therapy with continuous infusion ZVD. Our sample size was, however, small and the nutritional measure rather global; thus these findings have to be considered as very preliminary.",
keywords = "brain imaging, encephalopathy, human, neuropsychological test, pediatric HIV-1 disease",
author = "Pim Brouwers and Charles DeCarli and Heyes, {Melvyn P.} and Moss, {Howard A.} and Wolters, {Pamela L.} and Gareth Tudor-Williams and Civitello, {Lucy A.} and Pizzo, {Philip A.}",
year = "1996",
month = "10",
language = "English (US)",
volume = "126",
journal = "Journal of Nutrition",
issn = "0022-3166",
publisher = "American Society for Nutrition",
number = "10 SUPPL.",

}

TY - JOUR

T1 - Neurobehavioral manifestations of symptomatic HIV-1 disease in children

T2 - Can nutritional factors play a role?

AU - Brouwers, Pim

AU - DeCarli, Charles

AU - Heyes, Melvyn P.

AU - Moss, Howard A.

AU - Wolters, Pamela L.

AU - Tudor-Williams, Gareth

AU - Civitello, Lucy A.

AU - Pizzo, Philip A.

PY - 1996/10

Y1 - 1996/10

N2 - Central nervous system (CNS) abnormalities are significant and frequent complications of human immunodeficiency virus (HIV-1) infection in infants and children. Although the predominant cause of neurological and neuropsychological abnormalities appears to be related to HIV infection of the CNS, other factors including malnutrition may also play a role. We retrospectively evaluated the association of change in body weight with changes in neurocognitive function, ventricular brain ratio, and cerebrospinal quinolinic acid levels in a small cohort of children (n=15; mean age 6.3 years) with symptomatic HIV-1 disease before and after 6 months of antiretroviral therapy with continuous intravenous infusion of zidovudine (ZVD). Significant increases in weight and neurocognitive function as well as decreases in ventricular brain ratio and cerebrospinal quinolinic acid levels were noted after therapy. Only the relation between increase in weight and decrease in ventricular brain ratio was statistically significant (P< .01); contrary to expectations, an increase in weight seemed to correlate with a decrease in neurocognitive function (NS). Another group of children treated at the same time with oral intermittent ZVD, but otherwise receiving the same care did not show the same magnitude of improvement in neurocognitive function. These results seem to suggest that general supportive and medical care as well as nutritional factors may only play a limited role in the neurocognitive improvements after antiretroviral therapy with continuous infusion ZVD. Our sample size was, however, small and the nutritional measure rather global; thus these findings have to be considered as very preliminary.

AB - Central nervous system (CNS) abnormalities are significant and frequent complications of human immunodeficiency virus (HIV-1) infection in infants and children. Although the predominant cause of neurological and neuropsychological abnormalities appears to be related to HIV infection of the CNS, other factors including malnutrition may also play a role. We retrospectively evaluated the association of change in body weight with changes in neurocognitive function, ventricular brain ratio, and cerebrospinal quinolinic acid levels in a small cohort of children (n=15; mean age 6.3 years) with symptomatic HIV-1 disease before and after 6 months of antiretroviral therapy with continuous intravenous infusion of zidovudine (ZVD). Significant increases in weight and neurocognitive function as well as decreases in ventricular brain ratio and cerebrospinal quinolinic acid levels were noted after therapy. Only the relation between increase in weight and decrease in ventricular brain ratio was statistically significant (P< .01); contrary to expectations, an increase in weight seemed to correlate with a decrease in neurocognitive function (NS). Another group of children treated at the same time with oral intermittent ZVD, but otherwise receiving the same care did not show the same magnitude of improvement in neurocognitive function. These results seem to suggest that general supportive and medical care as well as nutritional factors may only play a limited role in the neurocognitive improvements after antiretroviral therapy with continuous infusion ZVD. Our sample size was, however, small and the nutritional measure rather global; thus these findings have to be considered as very preliminary.

KW - brain imaging

KW - encephalopathy

KW - human

KW - neuropsychological test

KW - pediatric HIV-1 disease

UR - http://www.scopus.com/inward/record.url?scp=0029836693&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029836693&partnerID=8YFLogxK

M3 - Article

C2 - 8861929

AN - SCOPUS:0029836693

VL - 126

JO - Journal of Nutrition

JF - Journal of Nutrition

SN - 0022-3166

IS - 10 SUPPL.

ER -